These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 20637335)
1. Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthle-cell neoplasms of the thyroid. Suh I; Vriens MR; Guerrero MA; Griffin A; Shen WT; Duh QY; Clark OH; Kebebew E Am J Surg; 2010 Jul; 200(1):41-6. PubMed ID: 20637335 [TBL] [Abstract][Full Text] [Related]
2. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553 [TBL] [Abstract][Full Text] [Related]
3. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy. Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976 [TBL] [Abstract][Full Text] [Related]
4. Preoperative serum thyroglobulin concentration as a predictive factor of malignancy in small follicular and Hürthle cell neoplasms of the thyroid gland. Petric R; Besic H; Besic N World J Surg Oncol; 2014 Sep; 12():282. PubMed ID: 25213012 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer. Milas M; Barbosa GF; Mitchell J; Berber E; Siperstein A; Gupta M Ann Surg Oncol; 2009 Feb; 16(2):473-80. PubMed ID: 19015922 [TBL] [Abstract][Full Text] [Related]
6. Fine-needle aspiration biopsies in the management of indeterminate follicular and Hurthle cell thyroid lesions. Mijović T; Rochon L; Gologan O; Hier MP; Black MJ; Young J; Payne RJ Otolaryngol Head Neck Surg; 2009 May; 140(5):715-9. PubMed ID: 19393417 [TBL] [Abstract][Full Text] [Related]
7. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy? Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114 [TBL] [Abstract][Full Text] [Related]
8. Management of follicular and Hürthle cell neoplasms of the thyroid gland. McHenry CR; Sandoval BA Surg Oncol Clin N Am; 1998 Oct; 7(4):893-910. PubMed ID: 9735140 [TBL] [Abstract][Full Text] [Related]
9. Predictive factors of carcinoma in 327 patients with follicular neoplasm of the thyroid. Besic N; Sesek M; Peric B; Zgajnar J; Hocevar M Med Sci Monit; 2008 Sep; 14(9):CR459-67. PubMed ID: 18758416 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery. Makarewicz J; Adamczewski Z; Knapska-Kucharska M; Lewiński A Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):485-9. PubMed ID: 17115345 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of galectin-3 as a marker for malignancy in follicular patterned thyroid lesions. Oestreicher-Kedem Y; Halpern M; Roizman P; Hardy B; Sulkes J; Feinmesser R; Stern Y Head Neck; 2004 Nov; 26(11):960-6. PubMed ID: 15386597 [TBL] [Abstract][Full Text] [Related]
13. Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas. Lin JD; Huang MJ; Hsu BR; Chao TC; Hsueh C; Liu FH; Liou MJ; Weng HF J Surg Oncol; 2002 May; 80(1):45-51. PubMed ID: 11967907 [TBL] [Abstract][Full Text] [Related]
14. Follicular and Hürthle cell carcinoma of the thyroid gland. Phitayakorn R; McHenry CR Surg Oncol Clin N Am; 2006 Jul; 15(3):603-23, ix-x. PubMed ID: 16882500 [TBL] [Abstract][Full Text] [Related]
15. [Follicular and Hurthle cell tumors of the thyroid gland. Possibilities of preoperative differential diagnosis]. Grineva EN; Goriushkina EV; Malakhova TV; Tsoĭ UA Vopr Onkol; 2004; 50(1):41-5. PubMed ID: 15088519 [TBL] [Abstract][Full Text] [Related]
16. Hurthle cell neoplasm of the thyroid gland. Ahmed M; Bin Yousef H; Greer W; Faraz H; Al Sobhi S; Al Zahrani A; Raef H; Al Ghamdi A; Al Kadhi Y; Al Dayel F ANZ J Surg; 2008 Mar; 78(3):139-43. PubMed ID: 18269475 [TBL] [Abstract][Full Text] [Related]
17. [Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma]. Zöphel K; Wunderlich G; Liepach U; Koch R; Bredow J; Franke WG Nuklearmedizin; 2001 Oct; 40(5):155-63. PubMed ID: 11727628 [TBL] [Abstract][Full Text] [Related]
18. The value of frozen section in intraoperative surgical management of thyroid follicular carcinoma. Dosen D; Turić M; Smalcelj J; Janusić R; Grgić MP; Separović V Head Neck; 2003 Jul; 25(7):521-8. PubMed ID: 12808654 [TBL] [Abstract][Full Text] [Related]
19. Preoperative serum thyroglobulin and changes in serum thyroglobulin during TSH suppression independently predict follicular thyroid carcinoma in thyroid nodules with a cytological diagnosis of follicular lesion. Kim HJ; Mok JO; Kim CH; Kim YJ; Kim SJ; Park HK; Byun DW; Suh K; Yoo MH Endocr Res; 2017 May; 42(2):154-162. PubMed ID: 27936964 [TBL] [Abstract][Full Text] [Related]
20. Accuracy of fine needle aspiration biopsy with and without the use of tumor markers in cytologically indeterminate thyroid lesions. Matesa N; Samija I; Kusić Z Coll Antropol; 2010 Mar; 34(1):53-7. PubMed ID: 20432733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]